Local Dose Effects for Late Gastrointestinal Toxicity After Hypofractionated and Conventionally Fractionated Modern Radiotherapy for Prostate Cancer in the HYPRO Trial

by Wilma D. Heemsbergen, Luca Incrocci, Floris J. Pos, Ben J. M. Heijmen, Marnix G. Witte
Published 2020-04-01

Clinical workflow for treating patients with a metallic hip prosthesis using magnetic resonance imaging-guided radiotherapy

by Rick Keesman, Erik van der Bijl, Tomas M. Janssen, Tineke Vijlbrief, Floris J. Pos, Uulke A. van der Heide
Published 2020-07-01

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer

by Charlotte L. Deijen, Gerbert L. Vrijenhoek, Eva E. Schaake, Wouter V. Vogel, Luc M.F. Moonen, Floris J. Pos, Henk G. van der Poel, Gerben R. Borst
Published 2021-09-01

Prostate fiducial marker detection with the use of multi-parametric magnetic resonance imaging

by Catarina Dinis Fernandes, Cuong V. Dinh, Marcel J. Steggerda, Leon C. ter Beek, Milena Smolic, Laurens D. van Buuren, Floris J. Pos, Uulke A. van der Heide
Published 2017-01-01

Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features

by Catarina Dinis Fernandes, Cuong V. Dinh, Iris Walraven, Stijn W. Heijmink, Milena Smolic, Joost J.M. van Griethuysen, Rita Simões, Are Losnegård, Henk G. van der Poel, Floris J. Pos, Uulke A. van der Heide
Published 2018-07-01

Quantitative MRI Changes During Weekly Ultra-Hypofractionated Prostate Cancer Radiotherapy With Integrated Boost

by Marcel A. van Schie, Petra J. van Houdt, Ghazaleh Ghobadi, Floris J. Pos, Iris Walraven, Hans C. J. de Boer, Cornelis A. T. van den Berg, Robert Jan Smeenk, Linda G. W. Kerkmeijer, Linda G. W. Kerkmeijer, Uulke A. van der Heide
Published 2019-12-01